• A New Look At Legend Biotech: Plenty Of Upside For Carvykti (NASDAQ:LEGN) Seeking Alpha Wed, 08 Jul 2026 18:46:06 GMT
• RBC Capital Adjusts Legend Biotech Price Target to $63 From $64, Maintains Outperform Rating Moomoo Tue, 07 Jul 2026 13:03:35 GMT
• RBC Capital Maintains Legend Biotech(LEGN.US) With Buy Rating, Cuts Target Price to $63 Moomoo Tue, 07 Jul 2026 12:31:00 GMT
• Legend Biotech Corporation (LEGN) Stock Analysis: Exploring a Promising 91% Potential Upside in Cancer Therapy DirectorsTalk Interviews Mon, 06 Jul 2026 09:19:18 GMT
• Biotech Stocks Are Surging in 2026. This One Stands Out After a Pullback. TheStreet Pro Sun, 05 Jul 2026 15:15:00 GMT
• legend biotech corp highlights cell therapy pipeline as shares trade on nasdaq Ad-hoc-news.de Fri, 03 Jul 2026 20:13:10 GMT
• Insider Sell Alert: Patrick Casey Sells 6,000 Shares of Legend B GuruFocus Thu, 02 Jul 2026 23:15:09 GMT
• Legend Biotech (LEGN) director sells 6,000 shares at $14.80 each in open-market trade Stock Titan Thu, 02 Jul 2026 20:06:40 GMT
• Legend Biotech (LEGN) CEO Ying Huang makes charitable gift of 3,382 shares Stock Titan Thu, 02 Jul 2026 20:06:25 GMT
• Legend Biotech Corporation Stock 12‑Month Price Target Cut to $55.21, Implies 85% Upside TradingView Thu, 02 Jul 2026 16:20:05 GMT
• form 144 legend biotech corp for: 30 june by investing.com Investing.com Nigeria Tue, 30 Jun 2026 15:43:01 GMT
• form 4 legend biotech corp for: 29 june by investing.com Investing.com Nigeria Tue, 30 Jun 2026 03:57:18 GMT
• legend biotech (nasdaq: legn) ceo disposes shares to cover rsu tax Stock Titan Tue, 30 Jun 2026 02:44:13 GMT
• Legend Biotech Corporation (LEGN) Stock Analysis: Exploring a Potential 100% Upside in the Biotech Sector DirectorsTalk Interviews Mon, 29 Jun 2026 09:27:18 GMT
• Legend Biotech (NASDAQ: LEGN) CEO disposes shares to cover RSU tax Stock Titan Mon, 29 Jun 2026 07:00:00 GMT
• Legend Biotech (LEGN) Reports LB2501 Progress, Is The Stock Still Cheap? simplywall.st Sun, 28 Jun 2026 04:21:40 GMT
• 2 Biotech Stocks Worth Buying Before Their Potential Buyouts Yahoo Finance Sat, 27 Jun 2026 07:00:00 GMT
• legend biotech (legn) reports lb2501 progress, is the stock still cheap? Sahm Sat, 27 Jun 2026 07:00:00 GMT
• price to sales forward of legend biotech corporation – nasdaq:legn TradingView Sat, 27 Jun 2026 02:44:58 GMT
• form 144 legend biotech corp for: 26 june by investing.com Investing.com South Africa Sat, 27 Jun 2026 02:30:53 GMT
• price to earnings forward of legend biotech corporation – nasdaq:legn TradingView Sat, 27 Jun 2026 00:55:35 GMT
• enterprise value to ebit forward of legend biotech corporation – nasdaq:legn TradingView Fri, 26 Jun 2026 22:33:08 GMT
• form 144 legend biotech corp for: 26 june by investing.com Investing.com Nigeria Fri, 26 Jun 2026 20:06:14 GMT
• legn (nasdaq) notice: director/entity proposes sale of 2,783 ads Stock Titan Fri, 26 Jun 2026 19:23:35 GMT
• enterprise value to ebitda forward of legend biotech corporation – nasdaq:legn TradingView Fri, 26 Jun 2026 13:31:11 GMT
• goldman sachs maintains legend biotech(legn.us) with buy rating, cuts target price to $41.42 Moomoo Fri, 26 Jun 2026 12:31:00 GMT
• what did the recent carvykti data reveal about its potential Kavout | AI Fri, 26 Jun 2026 09:40:28 GMT
• legend biotech (legn) 10k form and latest sec filings 2026 MarketBeat Fri, 26 Jun 2026 07:00:00 GMT
• Legend Biotech Corp. Sponsored ADR Actuals & Estimates (NASDAQ:LEGN) TradingView Fri, 26 Jun 2026 04:13:49 GMT
• enterprise value to revenue forward of legend biotech corporation – nasdaq:legn TradingView Thu, 25 Jun 2026 23:32:50 GMT
• price to book forward of legend biotech corporation – nasdaq:legn TradingView Thu, 25 Jun 2026 20:54:42 GMT
• Legend Biotech Corporation (LEGN) Price Target Raised to $49 on LB5006 Clinical Progress Yahoo Finance Thu, 25 Jun 2026 07:00:00 GMT
• 5 best healthcare stocks to buy according to wall street analysts Insider Monkey Wed, 24 Jun 2026 18:58:39 GMT
• After Apogee, 3 More Biotech Buyout Targets Wall Street Can’t Stop Watching Yahoo Finance Wed, 24 Jun 2026 07:00:00 GMT
• firm advises underwriters on legend biotech’s public offering Wilson Sonsini Wed, 24 Jun 2026 07:00:00 GMT
• legend biotech’s car t-cell therapy shows early promise in sclc, other tumors AJMC Tue, 23 Jun 2026 07:08:38 GMT
• Why Legend Biotech (LEGN) Is Down 17.3% After $226 Million Follow-On Offering Post LB2501 Data - And What's Next simplywall.st Tue, 23 Jun 2026 07:00:00 GMT
• Discussing the Broader Opportunity to Expand Patient Access to Cell Therapies - Legend Biotech Oncodaily Tue, 23 Jun 2026 07:00:00 GMT
• form 6k legend biotech corp for: 22 june by investing.com Investing.com South Africa Mon, 22 Jun 2026 21:19:35 GMT
• legend biotech (nasdaq: legn) prices $226m ads sale to raise cash Stock Titan Mon, 22 Jun 2026 20:20:25 GMT
• Legend Biotech’s CAR T-cell Therapy Shows Early Promise in SCLC, Other Tumors Journal of Managed Care Mon, 22 Jun 2026 07:00:00 GMT
• Legend Biotech (LEGN) Reports a Complete Response in Five of Six Patients at Its Highest Dose Yahoo Finance Mon, 22 Jun 2026 07:00:00 GMT
• Legend Biotech | 6-K: Report of foreign private issuer (related to financial reporting) Moomoo Mon, 22 Jun 2026 07:00:00 GMT
• why legend biotech (legn) is down 17.3% after $226 million follow-on offering post lb2501 data - and what's next Sahm Mon, 22 Jun 2026 07:00:00 GMT
• Legend Biotech Corporation Stock 12‑Month Price Target Raised to $57.53, Implies 106% Upside TradingView Sat, 20 Jun 2026 07:00:00 GMT
• legend biotech shares slide post-pricing of $226m public offering at $29.35 per unit MSN Fri, 19 Jun 2026 19:55:57 GMT
• legend biotech (legn) stock could be 51.2% undervalued after equity raise and lb2501 data simplywall.st Fri, 19 Jun 2026 07:00:00 GMT
• significant drop for legend biotech (legn) as shares fall 14.4% GuruFocus Thu, 18 Jun 2026 21:56:20 GMT
• legend biotech shares slide post-pricing of $226m public offering at $29.35 per unit MSN Thu, 18 Jun 2026 09:51:56 GMT
• Legend Biotech Announces Pricing of $226 Million Public Offering of ADSs Quiver Quantitative Thu, 18 Jun 2026 07:00:00 GMT
• legend biotech (legn) stock could be 51.2% undervalued after equity raise and lb2501 data Sahm Thu, 18 Jun 2026 07:00:00 GMT
• legend biotech corporation announces pricing of public offering The Manila Times Thu, 18 Jun 2026 07:00:00 GMT
• legend biotech (legn) raises ~$211.6m selling 7.7m adss; option for 1.155m more Stock Titan Thu, 18 Jun 2026 07:00:00 GMT
• legend biotech, sleep number and other big stocks moving lower in thursday's pre-market session Benzinga Thu, 18 Jun 2026 07:00:00 GMT
• legend biotech prices $226 million public offering at $29.35 by investing.com Investing.com Nigeria Thu, 18 Jun 2026 07:00:00 GMT
• legend biotech corporation announces proposed public offering The Manila Times Thu, 18 Jun 2026 07:00:00 GMT
• legend biotech (legn) 10k form and latest sec filings 2026 MarketBeat Thu, 18 Jun 2026 07:00:00 GMT
• legend biotech sets $29.35 share price for $226m offering Stock Titan Thu, 18 Jun 2026 01:24:26 GMT
• legend biotech stock falls on $225m share offering plan by investing.com Investing.com Nigeria Thu, 18 Jun 2026 00:42:34 GMT
• legend biotech commences $225m offering of american depositary shares scanx.trade Wed, 17 Jun 2026 21:41:40 GMT
• legend biotech (nasdaq: legn) files $225m ads offering to fund pipeline Stock Titan Wed, 17 Jun 2026 20:50:20 GMT
• legend biotech stock - oppenheimer reiterates buy rating AD HOC NEWS Wed, 17 Jun 2026 12:04:55 GMT
• Legend Biotech Corporation Announces Pricing of Public Offering GlobeNewswire Wed, 17 Jun 2026 07:00:00 GMT
• Legend Biotech prices $226 million public offering at $29.35 Investing.com Wed, 17 Jun 2026 07:00:00 GMT
• Legend Biotech seeks $225M in stock sale as markets stay open Stock Titan Wed, 17 Jun 2026 07:00:00 GMT
• Legend Biotech launches $225 million public share offering Investing.com Wed, 17 Jun 2026 07:00:00 GMT
• Legend Biotech - Commences $225 Million Public Offering Of American Depositary Shares TradingView Wed, 17 Jun 2026 07:00:00 GMT
• press release: legend biotech corporation announces proposed public offering Moomoo Wed, 17 Jun 2026 07:00:00 GMT
• legend biotech stock falls on $225m share offering plan Investing.com Wed, 17 Jun 2026 07:00:00 GMT
• legend biotech sets $29.35 share price for $226m offering Stock Titan Wed, 17 Jun 2026 07:00:00 GMT
• stocks to watch : smith & wesson, logistic properties of the americas, legend biotech marketscreener.com Wed, 17 Jun 2026 07:00:00 GMT
• legend biotech corp (legn) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Wed, 17 Jun 2026 05:26:43 GMT
• legend biotech corp (legn) dividends & stock splits: historical payouts and event timeline TradingKey Wed, 17 Jun 2026 05:20:46 GMT
• legend biotech (legn) jefferies 2024 global healthcare conference summary Quartr Tue, 16 Jun 2026 18:04:07 GMT
• legend biotech unveils strong first-in-human data for in vivo car-t lb2501 at eha 2026 The Globe and Mail Tue, 16 Jun 2026 12:44:00 GMT
• barclays keeps their buy rating on legend biotech (legn) The Globe and Mail Tue, 16 Jun 2026 08:40:00 GMT
• eddie cliff: enticing early data for the first in vivo car t in b cell lymphomas from legend biotech Oncodaily Tue, 16 Jun 2026 02:14:08 GMT
• legend biotech (legn) reports promising data for lb2501 in b-cel GuruFocus Mon, 15 Jun 2026 14:43:50 GMT
• oppenheimer maintains legend biotech(legn.us) with buy rating, maintains target price $75 Moomoo Mon, 15 Jun 2026 12:33:00 GMT
• piper sandler maintains legend biotech(legn.us) with buy rating, maintains target price $64 Moomoo Mon, 15 Jun 2026 11:31:00 GMT
• Cancer trial builds CAR-T cells inside patients, 100% response in 6 Stock Titan Mon, 15 Jun 2026 07:00:00 GMT
• legend biotech corporation (legn): investor outlook with 60.57% potential upside DirectorsTalk Interviews Mon, 15 Jun 2026 07:00:00 GMT
• legend biotech establishes clinical proof-of-concept for lb2501, a potential first-in-class in vivo cd19/cd20 dual-targeting car-t... GlobeNewswire Mon, 15 Jun 2026 07:00:00 GMT
• legend biotech (nasdaq: legn) unveils promising first-in-human lb2501 in vivo car-t results Stock Titan Mon, 15 Jun 2026 07:00:00 GMT
• legend biotech reports early trial success for in vivo car-t therapy Investing.com Mon, 15 Jun 2026 07:00:00 GMT
• legend bio rises after early-stage data for in vivo car-t therapy MSN Mon, 15 Jun 2026 02:00:09 GMT
• legend biotech (legn) unveils promising results for lb2501 car-t therapy GuruFocus Mon, 15 Jun 2026 01:04:48 GMT
• legend biotech (legn) unveils promising results for lb2501 car-t therapy GuruFocus Sun, 14 Jun 2026 21:36:40 GMT
• legend biotech (legn) jefferies 2024 global healthcare conference summary Quartr Sun, 14 Jun 2026 17:28:33 GMT
• legend biotech's lb2501 shows 100% response in phase 1 trial for relapsed b-cell lymphoma with good safety. Pluang Sun, 14 Jun 2026 07:45:43 GMT
• Legend Biotech Stock (LEGN) Opinions on In Vivo CAR-T Results Quiver Quantitative Sun, 14 Jun 2026 07:00:00 GMT
• Legend Biotech Establishes Clinical Proof-of-Concept for GlobeNewswire Sun, 14 Jun 2026 07:00:00 GMT
• Legend Biotech Reports Promising Phase 1 Results for LB2501, Achieving 100% Objective Response Rate in Relapsed/Refractory B-NHL P... Quiver Quantitative Sun, 14 Jun 2026 07:00:00 GMT
• single-dose lymphoma car-t from legend biotech hits 100% response at top dose Stock Titan Sun, 14 Jun 2026 07:00:00 GMT
• legend biotech | 6-k: report of foreign private issuer [rules 13a-16 and 15d-16] Moomoo Sun, 14 Jun 2026 07:00:00 GMT
• legend biotech (legn) is up 6.1% after early in vivo car-t data for lb2501 – what's changed simplywall.st Fri, 12 Jun 2026 07:00:00 GMT
• legend biotech conference spotlights carvykti's curative potential, earlier use MSN Wed, 10 Jun 2026 17:15:54 GMT
• legend bio rises after early-stage data for in vivo car-t therapy MSN Tue, 09 Jun 2026 16:33:27 GMT
• legend bio rises after early-stage data for in vivo car-t therapy MSN Mon, 08 Jun 2026 19:40:48 GMT
• legend biotech corp stock (us52490g1022): june trading momentum stands out AD HOC NEWS Mon, 08 Jun 2026 15:07:08 GMT
• legend biotech corporation (legn) stock analysis: unpacking the 76.56% potential upside DirectorsTalk Interviews Mon, 08 Jun 2026 09:21:48 GMT
• legend bio rises after early-stage data for in vivo car-t therapy MSN Sat, 06 Jun 2026 06:54:16 GMT
• new jersey jobs of the week: ai, biotech, historic preservation, and construction roles Jersey Digs Fri, 05 Jun 2026 15:22:56 GMT
• legend bio rises after early-stage data for in vivo car-t therapy MSN Fri, 05 Jun 2026 11:06:56 GMT
• why (legn) price action is critical for tactical trading Stock Traders Daily Fri, 05 Jun 2026 10:38:01 GMT
• assessing legend biotech (legn) valuation after positive early lb2501 car t therapy results Sahm Fri, 05 Jun 2026 07:00:00 GMT
• ubs maintains legend biotech(legn.us) with buy rating, maintains target price $49 Moomoo Fri, 05 Jun 2026 07:00:00 GMT
• barclays maintains legend biotech(legn.us) with buy rating, maintains target price $80 Moomoo Thu, 04 Jun 2026 09:31:00 GMT
• Legend Biotech (LEGN) Is Up 26.2% After Early In Vivo CAR-T Success in B-Cell Lymphoma Yahoo Finance Thu, 04 Jun 2026 07:00:00 GMT
• ubs adjusts legend biotech price target to $49 from $31, maintains buy rating marketscreener.com Thu, 04 Jun 2026 07:00:00 GMT
• why legend biotech (legn) is up 22.9% after early success with off‑the‑shelf in vivo car‑t simplywall.st Wed, 03 Jun 2026 18:32:57 GMT
• legn maintained by hc wainwright & co. -- price target raised to $65 GuruFocus Wed, 03 Jun 2026 14:34:29 GMT
• ubs maintains legend biotech(legn.us) with buy rating, raises target price to $49 Moomoo Wed, 03 Jun 2026 11:31:00 GMT
• Legend surges on early data for ‘in vivo’ lymphoma cell therapy BioPharma Dive Wed, 03 Jun 2026 07:00:00 GMT
• Legend soars on ‘best-in-class,’ ‘best-in-disease’ in vivo CAR T in early lymphoma study BioSpace Wed, 03 Jun 2026 07:00:00 GMT
• UBS raises Legend Biotech stock price target on NHL therapy outlook Investing.com Wed, 03 Jun 2026 07:00:00 GMT
• As Akeso takes center stage at ASCO, China biotech industry cements its coming of age Fierce Pharma Wed, 03 Jun 2026 07:00:00 GMT
• Legend Biotech Jumps 42% On New Data - Here's What Comes Next (NASDAQ:LEGN) Seeking Alpha Wed, 03 Jun 2026 07:00:00 GMT
• Legend shares leap on early in vivo CAR-T lymphoma data The Pharma Letter Wed, 03 Jun 2026 07:00:00 GMT
• legend's experimental cell therapy shows promise in blood cancer patients Reuters Wed, 03 Jun 2026 07:00:00 GMT
• raymond james reiterates legend biotech stock rating after rival approval Investing.com Wed, 03 Jun 2026 07:00:00 GMT
Legend Biotech Corporation(NASDAQ:LEGN) 
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in North America and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen re...
Website: https://legendbiotech.com/
Founded: 2014
Full Time Employees: 800
CEO: Yuan Xu
Sector: Healthcare
Industry: Biotechnology